Hansa Biopharma AB
Industry
- Biotechnology
- Large Molecule
- In Vitro Diagnostics
- Chemistry, Immunoassay
- Pharmaceuticals
Other Names/Subsidiaries
- Hansa Medical AB
Latest on Hansa Biopharma AB
Recent private placements and follow-on financings show that despite public company valuations being down across the board during the past two years, it still is possible to drum up investor support f
With the European rollout for Idefirix progressing steadily, Hansa Biopharma AB is now preparing to go stateside and has raised fresh funds for the submission and potential US launch of the kidney t
The US Food and Drug Administration is to decide by 29 May 2023 on whether or not to approve SRP-9001, Sarepta Therapeutics ’s gene therapy for Duchenne, which many hope will be a breakthrough agains
Biopharmaceutical company valuations overall still are down by double digits year-to-date, but as the second quarter transitioned into the third stock prices have begun to rise across the industry as